Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 0 | 1,840 |
| Gross Profit | N/A | N/A | N/A | N/A | 1,840 |
| Operating Expenses | 12,614 | 5,734 | 12,895 | 31,841 | 14,653 |
| Operating Income | -12,614 | -5,734 | -12,895 | -31,841 | -12,813 |
| Other Income | 96 | 159 | 352 | 233 | 45 |
| Pre-tax Income | -12,519 | -5,576 | -12,543 | -31,608 | -12,768 |
| Net Income Continuous | -12,519 | -5,576 | -12,543 | -31,608 | -12,768 |
| Net Income | $-12,519 | $-5,576 | $-12,543 | $-31,608 | $-12,768 |
| EPS Basic Total Ops | -129.10 | -69.54 | -5,532.65 | -21,425.06 | -11,115.69 |
| EPS Basic Continuous Ops | -129.10 | -69.54 | -5,531.93 | -21,421.83 | -11,110.85 |
| EPS Diluted Total Ops | -129.10 | -69.54 | -5,532.65 | -21,425.06 | -11,115.69 |
| EPS Diluted Continuous Ops | -129.10 | -69.54 | -5,531.93 | -21,421.83 | -11,110.85 |
| EPS Diluted Before Non-Recurring Items | -41.26 | -1,042.10 | -5,529.05 | -15,420.86 | -11,158.89 |
| EBITDA(a) | $-12,607 | $-5,730 | $-12,885 | $-31,835 | $-12,794 |